Skip to main content
Year archive

ABL Bio Inc. — 2020 filings

All 30 regulatory filings released by ABL Bio Inc. (298380) in 2020, sourced directly from the official regulator.

30 Filings
2020 Period
2020 filings (30)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2020-12-14 Korean
분기보고서 (2020.09)
Interim / Quarterly Report 9M 2020
2020-11-16 Korean
기타경영사항(자율공시)(레고켐바이오의 CStone Pharmaceuticals 기술이전 수익 배분 건)
Regulatory Filings
2020-10-29 Korean
기타경영사항(특허권취득)(자율공시)(DLL4에 특이적으로 결합하는 신규한 단일클론항체 및 이의 용도 중국 특허 취득)
Regulatory Filings
2020-10-23 Korean
기타경영사항(특허권취득)(자율공시)(항 α-syn 항체 및 그 용도)
Regulatory Filings
2020-09-15 Korean
기업설명회(IR)개최
Report Publication Announcement
2020-09-14 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2020-08-19 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-08-13 Korean
반기보고서 (2020.06)
Interim / Quarterly Report H1 2020
2020-08-13 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2020-08-05 Korean
분기보고서 (2020.03)
Interim / Quarterly Report Q1 2020
2020-05-15 Korean
주식매수선택권행사
Share Issue/Capital Change
2020-03-31 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2020-03-31 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-03-31 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-03-31 Korean
사업보고서 (2019.12)
Audit Report / Information FY 2019
2020-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2020-03-24 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2020-03-24 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2020-03-24 Korean
투자판단관련주요경영사항(ABL001 국내 제1b/2a상 임상시험 계획 승인)
Regulatory Filings
2020-03-17 Korean
감사보고서제출
Audit Report / Information FY 2019
2020-03-16 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2020-03-06 Korean
주주총회소집공고
AGM Information
2020-03-06 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2020-03-05 Korean
기타경영사항(특허권취득)(자율공시)(DLL4에 특이적으로 결합하는 신규한 단일클론항체 및 이의 용도 유럽특허취득)
Regulatory Filings
2020-02-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2020-02-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-02-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-02-12 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports
2020-02-07 Korean
기업설명회(IR)개최
Regulatory Filings
2020-02-04 Korean